Invention Grant
- Patent Title: Solid pharmaceutical gold-based composition
-
Application No.: US18606260Application Date: 2024-03-15
-
Publication No.: US12103939B2Publication Date: 2024-10-01
- Inventor: Anvarhusein A. Isab , Adam Ahmed Abdullah Sulaiman
- Applicant: KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS
- Applicant Address: SA Dhahran
- Assignee: KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS
- Current Assignee: KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS
- Current Assignee Address: SA Dhahran
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Main IPC: A61P35/00
- IPC: A61P35/00 ; C07F1/00

Abstract:
A gold(III) complex of formula (I) or formula (II)
wherein R1 and R2 are each independently a hydrogen, an optionally substituted alkyl, an optionally substituted cycloalkyl, an optionally substituted arylalkyl, or an optionally substituted aryl; R3 and R4 are each independently a hydrogen, an optionally substituted alkyl, an optionally substituted cycloalkyl, an optionally substituted arylalkyl, an optionally substituted aryl, an optionally substituted heterocyclyl, an optionally substituted alkoxy, a hydroxyl, a halo, a nitro, a cyano, a N-monosubstituted amino group, or a N,N-disubstituted amino group; and X is Cl, Br, or I. A pharmaceutical composition containing the gold(III) complex of formula (I) or (II), and a method of treating cancer are included.
wherein R1 and R2 are each independently a hydrogen, an optionally substituted alkyl, an optionally substituted cycloalkyl, an optionally substituted arylalkyl, or an optionally substituted aryl; R3 and R4 are each independently a hydrogen, an optionally substituted alkyl, an optionally substituted cycloalkyl, an optionally substituted arylalkyl, an optionally substituted aryl, an optionally substituted heterocyclyl, an optionally substituted alkoxy, a hydroxyl, a halo, a nitro, a cyano, a N-monosubstituted amino group, or a N,N-disubstituted amino group; and X is Cl, Br, or I. A pharmaceutical composition containing the gold(III) complex of formula (I) or (II), and a method of treating cancer are included.
Public/Granted literature
- US20240279242A1 SOLID PHARMACEUTICAL GOLD-BASED COMPOSITION Public/Granted day:2024-08-22
Information query
IPC分类:
A | 人类生活必需 |
A61 | 医学或兽医学;卫生学 |
A61P | 化合物或药物制剂的特定治疗活性 |
A61P35/00 | 抗肿瘤药 |